 Participants will be selected for participation in the study depending on the findings of the EPTPartner Notification Screening Protocol. Participants in the EPTPartner Notification Screening Protocol diagnosed with urethritis andor proctitis, or Gonorrhea andor Chlamydia in the urethra, rectum, or oropharynx will be eligible for enrollment in the EPT trial protocol. 